Esomeprazole and omeprazole may boost the serum concentrations of benzodiazepines (by using CYP2C19 inhibition) leading to greater adverse effects like drowsiness, although the clinical relevance is lower in the majority of clients – monitor the patient for adverse effects (e. The purpose of this review was To guage the anxiolytic, https://medeusresearchchem.com/product-category/research-chemicals/